Cite

HARVARD Citation

    Spriano, F. et al. (2019). Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP‐319 in pre‐clinical models of aggressive lymphomas. British journal of haematology. pp. 595-601. [Online]. 
  
Back to record